CABA Cabaletta Bio, Inc.
$1.52▲ +4.47%
Healthcare
Other
After hours
$1.52▲ +0.00%
Oct 28, 4:01 PM ET
Volume 5.82M
Avg Volume (10D) 4.98M
Key Metrics & Fundamentals
Market Cap
$257.71M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.32 - 4.23
% vs 50 MA
-39.24%
% vs 200 MA
-49.22%
RSI-14
32.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$41.51M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$50.13M
COGS
–
Operating Exp
$52.02M
Operating Income
-$52.02M
EBIT
-$52.02M
Pretax Income
-$51.02M
Net Income
-$51.02M
EPS (Diluted)
-0.34
Price & Volume History
Loading chart…
Recent News
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 5, 2026 4:01 PM ET
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
BioPharma Dive · Sep 2, 2026 8:32 AM ET
Cabaletta Bio to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:00 AM ET
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 13, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CABA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.